LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
ClosedPublished 18 May 2022

22nd Century Group, Inc. /
GVB Biopharma

22nd Century Group adds GVB Biopharma’s hemp product business

Price
$4.5m
Stage
Closed
Source · 18 May 2022
See the source
01 / Buyer22nd Century Group, Inc.
02 / TargetGVB Biopharma
01

What happened

22nd Century Group, Inc. closed its acquisition of substantially all of GVB Biopharma’s assets dedicated to hemp-based cannabinoid extraction, refinement, contract manufacturing and product development on May 13, 2022.

Consideration included the assumption of approximately $4.5 million of debt, certain transaction costs and 32,900,000 shares of common stock. Terms weren't disclosed.

02

The source

Everything on this page comes from the source below.

01
Source · Source

22nd Century Group adds GVB Biopharma’s hemp product business

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.